Sankei Chemical Co., Ltd. (FKSE:4995)
Japan · Delayed Price · Currency is JPY 1,750.00
0.00 (0.00%)
At close: Jul 21, 2026
Sankei Chemical Income Statement
Financials in millions JPY. Fiscal year is December - November.
Millions JPY. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 6,923 | 6,444 | 6,052 | 5,998 | 7,242 | 7,032 | |
Revenue Growth (YoY) | 8.04% | 6.48% | 0.90% | -17.18% | 2.99% | 4.78% |
Cost of Revenue | 5,363 | 4,839 | 4,684 | 4,665 | 5,672 | 5,212 |
Gross Profit | 1,560 | 1,605 | 1,368 | 1,333 | 1,570 | 1,820 |
Selling, General & Admin | 1,162 | 1,142 | 1,099 | 1,111 | 1,119 | 1,131 |
Research & Development | 282 | 282 | 224 | 233 | 218 | 183 |
Other Operating Expenses | - | - | - | - | - | 113 |
Operating Expenses | 1,444 | 1,424 | 1,323 | 1,344 | 1,337 | 1,427 |
Operating Income | 116 | 181 | 45 | -11 | 233 | 393 |
Interest Expense | -26 | -24 | -21 | -17 | -14 | -13 |
Interest & Investment Income | 10 | 12 | 16 | 14 | 13 | 9 |
Earnings From Equity Investments | 105 | 87 | 66 | 30 | 31 | 40 |
Other Non Operating Income (Expenses) | 22 | 23 | 31 | 21 | 37 | 23 |
EBT Excluding Unusual Items | 227 | 279 | 137 | 37 | 300 | 452 |
Gain (Loss) on Sale of Investments | - | - | 16 | 16 | - | - |
Gain (Loss) on Sale of Assets | - | 1 | 64 | - | - | - |
Asset Writedown | -1 | -1 | - | -1 | -2 | -9 |
Other Unusual Items | -9 | -66 | - | 1 | - | - |
Pretax Income | 217 | 213 | 217 | 53 | 298 | 443 |
Income Tax Expense | 25 | 29 | 51 | 10 | 80 | 120 |
Earnings From Continuing Operations | 192 | 184 | 166 | 43 | 218 | 323 |
Minority Interest in Earnings | -3 | -3 | -34 | -7 | -6 | -10 |
Net Income | 189 | 181 | 132 | 36 | 212 | 313 |
Net Income to Common | 189 | 181 | 132 | 36 | 212 | 313 |
Net Income Growth | -4.54% | 37.12% | 266.67% | -83.02% | -32.27% | 114.38% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change (YoY) | -0.02% | -1.24% | -4.00% | -1.35% | -0.02% | -0.02% |
EPS (Basic) | 210.90 | 201.95 | 145.44 | 38.08 | 221.23 | 326.57 |
EPS (Diluted) | 210.90 | 201.95 | 145.44 | 38.08 | 221.23 | 326.57 |
EPS Growth | -4.52% | 38.85% | 281.95% | -82.79% | -32.26% | 114.42% |
Free Cash Flow | 496 | 357 | 387 | -462 | -270 | 521 |
Free Cash Flow Per Share | 553.48 | 398.32 | 426.42 | -488.69 | -281.76 | 543.59 |
Dividend Per Share | 30.000 | 30.000 | 25.000 | 25.000 | 30.000 | 25.000 |
Dividend Growth | 20.00% | 20.00% | - | -16.67% | 20.00% | 31.58% |
Gross Margin | 22.53% | 24.91% | 22.60% | 22.22% | 21.68% | 25.88% |
Operating Margin | 1.68% | 2.81% | 0.74% | -0.18% | 3.22% | 5.59% |
Profit Margin | 2.73% | 2.81% | 2.18% | 0.60% | 2.93% | 4.45% |
Free Cash Flow Margin | 7.17% | 5.54% | 6.40% | -7.70% | -3.73% | 7.41% |
EBITDA | 265 | 315 | 171 | 107 | 336 | 500 |
EBITDA Margin | 3.83% | 4.89% | 2.83% | 1.78% | 4.64% | 7.11% |
D&A For EBITDA | 149 | 134 | 126 | 118 | 103 | 107 |
EBIT | 116 | 181 | 45 | -11 | 233 | 393 |
EBIT Margin | 1.68% | 2.81% | 0.74% | -0.18% | 3.22% | 5.59% |
Effective Tax Rate | 11.52% | 13.61% | 23.50% | 18.87% | 26.85% | 27.09% |